244 related articles for article (PubMed ID: 16651409)
1. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
2. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
Schuldiner O; Benvenisty N
Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
[TBL] [Abstract][Full Text] [Related]
3. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.
Soucek L; Lawlor ER; Soto D; Shchors K; Swigart LB; Evan GI
Nat Med; 2007 Oct; 13(10):1211-8. PubMed ID: 17906636
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
6. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
Pascal SM; Guiot Y; Pelengaris S; Khan M; Jonas JC
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E92-102. PubMed ID: 18413670
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel Myc target genes with a potential role in lymphomagenesis.
Marinkovic D; Marinkovic T; Kokai E; Barth T; Möller P; Wirth T
Nucleic Acids Res; 2004; 32(18):5368-78. PubMed ID: 15477387
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
10. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
16. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
17. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
18. Omomyc expression in skin prevents Myc-induced papillomatosis.
Soucek L; Nasi S; Evan GI
Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
[TBL] [Abstract][Full Text] [Related]
19. Functions of myc:max in the control of cell proliferation and tumorigenesis.
Hurlin PJ; Dezfouli S
Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
[TBL] [Abstract][Full Text] [Related]
20. Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
Cheung RS; Brooling JT; Johnson MM; Riehle KJ; Campbell JS; Fausto N
Carcinogenesis; 2007 Dec; 28(12):2624-31. PubMed ID: 17698969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
